CAPTRUST Financial Advisors
ARNA

CAPTRUST Financial Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-272
Closed -$25K – 5292
2021
Q4 		$25K Buy
272
+163
+150% +$10.7K ﹤0.01% 3158
2021
Q3 		$6K Sell
109
-150
-58% -$8.86K ﹤0.01% 3905
2021
Q2 		$18K Sell
259
-768
-75% -$50.1K ﹤0.01% 3193
2021
Q1 		$71K Buy
1,027
+114
+12% +$8.77K ﹤0.01% 2196
2020
Q4 		$70K Sell
913
-16
-2% -$1.2K ﹤0.01% 1687
2020
Q3 		$70K Buy
929
+542
+140% +$36.1K ﹤0.01% 1515
2020
Q2 		$24K Buy
+387
New +$21.3K ﹤0.01% 1876
2019
Q4 		– Sell
-40
Closed -$2K – 1964
2019
Q3 		$2K Sell
40
-40
-50% -$2.25K ﹤0.01% 1826
2019
Q2 		$5K Hold
80
– – ﹤0.01% 1670
2019
Q1 		$4K Hold
80
– – ﹤0.01% 1598
2018
Q4 		$3K Hold
80
– – ﹤0.01% 1460
2018
Q3 		$4K Buy
+80
New +$3.24K ﹤0.01% 1418

CAPTRUST Financial Advisors's ARNA Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 272 shares — an estimated $25K sold.

CAPTRUST Financial Advisors first reported a position in ARNA in Q3 2018 and held it in 12 quarters. The position peaked at $71K in Q1 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • CAPTRUST Financial Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 272 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $25K.
  • CAPTRUST Financial Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's Arena Pharmaceuticals Inc position peaked at $71K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.